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The MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) locus is misregulated in many human
cancers and produces an abundant long nuclear-retained noncoding RNA. Despite being transcribed by RNA
polymerase II, the 39 end of MALAT1 is produced not by canonical cleavage/polyadenylation but instead by
recognition and cleavage of a tRNA-like structure by RNase P. Mature MALAT1 thus lacks a poly(A) tail yet is
expressed at a level higher than many protein-coding genes in vivo. Here we show that the 39 ends of MALAT1 and
the MEN b long noncoding RNAs are protected from 39–59 exonucleases by highly conserved triple helical
structures. Surprisingly, when these structures are placed downstream from an ORF, the transcript is efficiently
translated in vivo despite the lack of a poly(A) tail. The triple helix therefore also functions as a translational
enhancer, and mutations in this region separate this translation activity from simple effects on RNA stability or
transport. We further found that a transcript ending in a triple helix is efficiently repressed by microRNAs in vivo,
arguing against a major role for the poly(A) tail in microRNA-mediated silencing. These results provide new
insights into how transcripts that lack poly(A) tails are stabilized and regulated and suggest that RNA triple-helical
structures likely have key regulatory functions in vivo.
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Processing the 39 end of a nascent transcript is critical for
termination of RNA polymerase and for ensuring the
proper functionality of the mature RNA. During normal
development and in the progression of diseases such as
cancer, 39 end cleavage site usage frequently changes,
resulting in additional sequence motifs being included (or
excluded) at the 39 ends of mature RNAs that can affect
the transcripts’ stability, subcellular localization, or func-
tion (for review, see Lutz and Moreira 2011). Virtually all
long RNA polymerase II (Pol II) transcripts terminate in
a poly(A) tail that is generated by endonucleolytic cleav-
age followed by the addition of adenosine (A) residues
in a nontemplated fashion (Moore and Sharp 1985; for
review, see Colgan and Manley 1997; Zhao et al. 1999;
Proudfoot 2004). However, recent large-scale studies of
the human transcriptome indicate that transcription is
pervasive throughout the genome (for review, see Wilusz
et al. 2009) and suggest that a significant fraction (possi-
bly >25%) of long Pol II transcripts present in cells may
lack a canonical poly(A) tail (Cheng et al. 2005; Wu et al.
2008; Yang et al. 2011a). Although some of these transcripts
are likely degradation intermediates, there are well-charac-
terized stable Pol II transcripts that lack a poly(A) tail, such
as replication-dependent histone mRNAs. Following U7
small nuclear RNA (snRNA)-guided endonucleolytic
cleavage at their 39 ends, histone mRNAs have a highly
conserved stem–loop structure in their 39 untranslated
regions (UTRs) that is functionally analogous to a poly(A)
tail, as it ensures RNA stability and enhances trans-
lational efficiency (for review, see Marzluff et al. 2008).
Recent work has identified additional Pol II transcripts
that are subjected to noncanonical 39 end processing
mechanisms (for review, see Wilusz and Spector 2010).
In particular, enzymes with well-known roles in other
RNA processing events, such as pre-mRNA splicing (Box
et al. 2008) and tRNA biogenesis, have been shown to
cleave certain nascent transcripts to generate mature 39
ends. In its well-characterized role, RNase P endonucleo-
lytically cleaves tRNA precursors to produce the mature
59 termini of functional tRNAs (for review, see Kirsebom
2007). One of us (Wilusz et al. 2008) previously showed
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that RNase P also generates themature 39 end of the long
noncoding RNA MALAT1 (metastasis-associated lung
adenocarcinoma transcript 1), also known as NEAT2,
despite the presence of a nearby polyadenylation sig-
nal. Cleavage by RNase P simultaneously generates the
mature 39 end of the ;6.7-kb MALAT1 noncoding RNA
and the 59 end of a small tRNA-like transcript (Fig. 1A).
Additional enzymes involved in tRNA biogenesis, includ-
ing RNase Z and the CCA-adding enzyme, further process
the small RNA to generate the mature 61-nucleotide (nt)
transcript known as mascRNA (MALAT1-associated small
cytoplasmic RNA) (Wilusz et al. 2008).
The long MALAT1 transcript is retained in the nucleus
in nuclear speckles (Hutchinson et al. 2007), where it has
been proposed to regulate alternative splicing (Tripathi
et al. 2010), transcriptional activation (Yang et al. 2011b),
and the expression of nearby genes in cis (Nakagawa et al.
2012; Zhang et al. 2012). Although the MALAT1 locus
appears to be dispensable for mouse development (Eissmann
et al. 2012; Nakagawa et al. 2012; Zhang et al. 2012),
MALAT1 is overexpressed in many human cancers (Ji
et al. 2003; Lin et al. 2007; Lai et al. 2011), suggesting that
it may have an important function during cancer pro-
gression. Furthermore, chromosomal translocation break-
points (Davis et al. 2003; Kuiper et al. 2003; Rajaram et al.
2007) as well as point mutations and short deletions (Ellis
et al. 2012) associated with cancer have been identified
within MALAT1.
Despite lacking a canonical poly(A) tail, MALAT1 is
among the most abundant long noncoding RNAs in
mouse and human cells. In fact, MALAT1 is expressed
at a level comparable with or higher than many protein-
coding genes, including b-actin or GAPDH (Zhang et al.
2012). How, then, is the 39 end of MALAT1 protected
from degradation? As previously noted, although the 39
end of MALAT1 is generated via a mechanism distinct
from canonical cleavage/polyadenylation, the mature
MALAT1 transcript has a short A-rich tract on its 39
end (Wilusz et al. 2008; Wilusz and Spector 2010). Rather
than being added on post-transcriptionally, as occurs
during polyadenylation, the MALAT1 poly(A) tail-like
moiety is encoded in the genome and thus is part of the
nascent transcript (Fig. 1A). From humans to fish, this
A-rich motif, along with two upstream U-rich motifs and
a stem–loop structure, is highly evolutionarily conserved
(Fig. 1B), suggesting the functional relevance of these
sequences. Similar highly conserved A- and U-rich motifs
are present at the 39 end of the MEN b long nuclear-
retained noncoding RNA, also known as NEAT1_2,
which is also processed at its 39 end by RNase P (Fig.
1C; Sunwoo et al. 2009). However, the function of these
motifs as well as the molecular mechanism by which the
39 ends of MALAT1 andMEN b are protected to allow the
transcripts to accumulate to high levels have not been
investigated.
Here, we use a newly developed expression plasmid
that accurately recapitulates MALAT1 39 end processing
in vivo to show that these highly conserved A- and U-rich
motifs form a triple-helical structure. Formation of the
triple helix does not affect RNase P processing or
mascRNA biogenesis but is instead critical for protecting
the 39 end of MALAT1 from 39–59 exonucleases. Surpris-
ingly, when the 39 end of MALAT1 or MEN b was placed
downstream from an ORF, the transcript was efficiently
translated in vivo despite the absence of a poly(A) tail.
The triple helix structure thus strongly promotes both
RNA stability and translation, suggesting that these long
noncoding RNAs may interact with the protein synthesis
machinery or even be translated under certain conditions.
In addition, mutational analysis was used to show that
the RNA stability and translational control functions can
be separated. Finally, as this expression system provides
a unique way to generate a stable transcript lacking
a poly(A) tail in vivo, we explored the role of the poly(A)
tail in microRNA-mediated repression. These results
provide important new insights into how MALAT1,
MEN b, and likely other transcripts that lack a poly(A)
tail are stabilized, regulated, and thus able to perform
important cellular functions.
Results
Generation of an expression plasmid that accurately
recapitulates MALAT1 39 end processing
Although it is clear that MALAT1 is cleaved to generate
mascRNA (Wilusz et al. 2008), a plasmid expression
system that recapitulates this processing event in vivo
has not been reported. We thus set out to generate such
a plasmid by inserting downstream from a CMV pro-
moter the coral green fluorescent protein (cGFP) ORF
followed by a 174-nt fragment of the 39 end of the mouse
MALAT1 locus (nucleotides 6581–6754 of mMALAT1)
(Fig. 1D). This region, denoted as mMALAT1_39, is highly
evolutionarily conserved from humans to zebrafish (Fig.
1B) and includes the well-conserved U- and A-rich motifs,
the RNase P cleavage site (after nucleotide 6690), and
mascRNA (nucleotides 6691–6748). As a control, a plas-
mid with the mMALAT1_39 region cloned downstream
from cGFP in the antisense direction was generated to
verify that mascRNA expression is dependent on process-
ing from the CMV-driven transcript.
The CMV-cGFP-mMALAT1_39 sense and antisense
plasmids were transiently transfected into human HeLa
cells, and total RNA was isolated 24 h later. For this
system to accurately recapitulate MALAT1 39 end pro-
cessing, it must generate two transcripts: the ;850-nt
cGFP-MALAT1_39 RNA and mature (61-nt) mouse
mascRNA that has been processed by RNases P and Z
as well as by the CCA-adding enzyme (Fig. 1D). There are
four sequence changes between mouse and human
mascRNA (Wilusz et al. 2008), allowing us to design
oligo probes that either distinguish between the homo-
logs (probe denoted as ‘‘mouse mascRNA only’’ in Fig. 1E)
or detect both mouse and human mascRNA (probe
denoted as ‘‘all mascRNA’’ in Fig. 1E) by Northern blot
analysis. In cells transfected with the sense, but not
antisense, expression plasmid, mature mascRNA was
generated and expressed ;16-fold over the level observed
in mock-treated cells (Fig. 1E). 39 RACE PCR was used to
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confirm that mascRNA generated from the plasmid was
properly processed and had CCA post-transcriptionally
added to its 39 end (data not shown). In parallel, mutant
mascRNA transcripts expressed using this plasmid were
subjected to CCACCA addition and rapidly degraded
in vivo (Supplemental Fig. 1), confirming our previous
finding that the CCA-adding enzyme plays a key role
in tRNA quality control (Wilusz et al. 2011). We thus
conclude that our plasmid generates bona fide mascRNA.
To determine whether the sense plasmid expresses
cGFP-MALAT1_39 RNA that is stable and properly pro-
cessed by RNase P at its 39 end in vivo, total RNA from
the transfections was first hybridized to an oligo comple-
mentary to near the 39 end of the cGFPORF and subjected
Figure 1. The 39 end of MALAT1 is highly conserved and cleaved by RNase P. (A) Although there is a polyadenylation signal at the 39
end of the MALAT1 locus, MALAT1 is primarily processed via an upstream cleavage mechanism that is mediated by the tRNA
biogenesis machinery. RNase P cleavage simultaneously generates the mature 39 end of MALAT1 and the 59 end of mascRNA. The
tRNA-like small RNA is subsequently cleaved by RNase Z and subjected to CCA addition. (B) Immediately upstream of the MALAT1
RNase P cleavage site (denoted by an arrow) is a highly evolutionarily conserved A-rich tract. Further upstream are two nearly perfectly
conserved U-rich motifs separated by a predicted stem–loop structure. (C) Similar motifs are present upstream of the MEN b RNase
P cleavage site. (D) The CMV-cGFP-mMALAT1_39 sense expression plasmid was generated by placing nucleotides 6581–6754 of mouse
MALAT1 downstream from the cGFP ORF. No polyadenylation signal is present at the 39 end. (E) After transfecting the plasmids into
HeLa cells, Northern blots were performed to detect expression of mascRNA and cGFP-MALAT1_39 RNA. To verify that the 39 end
of cGFP-MALAT1_39 RNA was accurately generated and that no additional nucleotides were added post-transcriptionally, RNase
H digestion was performed prior to Northern blot analysis.
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to RNase H digestion. Cleavage of the transcript to a
smaller size allowed Northern blots with a high resolu-
tion to be performed to verify the accuracy of RNase P
cleavage. A single band of the expected size (190 nt) was
observed with the sense, but not antisense, plasmid (Fig.
1E). These results indicate that the cGFP-MALAT1_39
sense primary transcript is efficiently cleaved by RNase P
to generate both expected mature transcripts (Fig. 1D)
and thus accurately recapitulates 39 end processing of
MALAT1 in vivo. The antisense plasmid likely failed to
produce a stable cGFPmRNA, as the transcript contained
no functional polyadenylation signals, causing the tran-
script to be rapidly degraded by nuclear surveillance
pathways.
As mascRNA is efficiently produced from the CMV
promoter-driven transcript (Fig. 1E), we conclude that the
MALAT1 promoter is not required for the recruitment of
RNase P or any of the other tRNA processing factors to
the nascent RNA. Furthermore, we found that the only
region of the MALAT1 primary transcript that is required
for mascRNA generation in vivo is the tRNA-like struc-
ture itself (Supplemental Fig. 2). Consistent with current
models of substrate recognition by RNase P (Kirsebom
2007), the enzyme will probably recognize and cleave any
tRNA-like structure, regardless of the promoter used to
generate the transcript. Indeed, placing theMEN b tRNA-
like structure downstream from cGFP in our expression
system similarly resulted in efficient RNase P cleavage
(Supplemental Fig. 3).
The conserved U-rich motifs protect the 39 end
of MALAT1 from degradation
As the highly conserved U- and A-rich motifs present
immediately upstream of the MALAT1 RNase P cleavage
site were not required for mascRNA biogenesis (Fig. 1B;
Supplemental Fig. 2), we hypothesized that they may
instead function to prevent nuclear export of MALAT1
and/or stabilize the long noncoding RNA post-RNase P
cleavage. Using biochemical fractionation to separate
nuclear and cytoplasmic total RNA from transfected
HeLa cells, we found that the cGFP-MALAT1_39 reporter
RNA was efficiently exported to the cytoplasm (Fig. 2B).
In fact, the transcript was exported as efficiently as a cGFP
transcript ending in a canonical poly(A) tail (Fig. 2A,B).
Therefore, the 39 end of MALAT1 does not function in
nuclear retention. We instead identified a region within
the body of mouse MALAT1 (nucleotides 1676–3598)
that, when inserted into our expression construct (to
generate the CMV-SpeckleF2-mMALAT1_39 plasmid)
(Fig. 2A), was sufficient to cause nuclear retention
(Fig. 2C). This is consistent with previous reports that
indicated that this region is important for targeting
endogenous MALAT1 to nuclear speckles (Tripathi et al.
2010; Miyagawa et al. 2012).
To instead explore a possible role for the highly
conserved U-rich motifs in MALAT1 RNA stability, we
generated and transfected cGFP-mMALAT1_39 expres-
sion plasmids containing 5-nt mutations in U-rich motif
1, U-rich motif 2, or both motifs (Fig. 2D). These muta-
tions had no effect on RNase P cleavage or mascRNA
biogenesis (Fig. 2E, bottom) but caused the mature
cGFP-MALAT1_39 RNA to be efficiently degraded
(Fig. 2E, top). Introducing similar mutations into the
nuclear-retained reporter transcript also caused the RNA
to be undetectable byNorthern blot analysis (Supplemental
Fig. 4B), indicating that U-rich motifs 1 and 2 are both
required for stabilizing the 39 end of MALAT1 in the
nucleus and cytoplasm.
A ligation-based 39 RACE PCR approach was used to
gain insight into the mechanism by which the mutant
transcripts are degraded. In addition to detecting tran-
scripts simply degraded from their 39 ends to various extents,
we surprisingly detected numerous cGFP-MALAT1_39
transcripts ending in short post-transcriptionally added
U-rich tails (10 out of 56 sequenced RACE clones),
implicating uridylation in the degradation of both the
wild-type and mutant MALAT1 39 ends (Fig. 2F). Several
degradation patterns were observed: (1) untemplated
adenylation of the MALAT1 39 end prior to uridylation
(e.g., Mut U1 RACE #1), (2) addition of a U-rich tail to the
full-length transcript (e.g., Mut U2 RACE #1), and (3)
partial degradation of the 39 end prior to uridylation (e.g.,
wild-type RACE #1) (Fig. 2F). This last pattern is partic-
ularly interesting, as it suggests that a 39–59 exonuclease
stalled as it was degrading theMALAT1 39 end. TheU-tail
was then likely added to provide a new single-stranded
tail for an exonuclease to recognize and restart the decay
process (Houseley et al. 2006). We also detected uridy-
lated decay intermediates using the nuclear-retained re-
porter transcript (Supplemental Fig. 4C), indicating that
uridylation likely occurs in both the nucleus and the
cytoplasm. These results indicate that U-rich motifs
1 and 2 are likely critical for stabilizing the 39 end of
MALAT1 by preventing uridylation and degradation by
39–59 exonucleases.
A triple helix forms at the 39 ends of MALAT1
and MEN b
Having identified U-rich motifs 1 and 2 as being critical
for MALAT1 39 end stability, we investigated the mini-
mal sequence elements required to stabilize the 39 end of
the cGFP-MALAT1_39 transcript. Using extensive muta-
genesis, we found that 51 of the 110 nt at the 39 end of
MALAT1 (Comp.14) (Fig. 2D) can be removed with little
or no effect on cGFP-MALAT1_39 RNA stability (Fig. 2G;
Supplemental Fig. 5). Consistent with the evolutionary
conservation patterns of MALAT1 (Fig. 1B) and MEN b
(Fig. 1C), the well-conserved A- and U-rich motifs as well
as the bottom half of the conserved stem–loop are re-
quired for cGFP-MALAT1_39 stability (Figs. 2D, 3A). In
contrast, more divergent regions, such as the sequences
between U-rich motif 2 and the A-rich tract, either are
dispensable or have only a minor supporting role in
stabilizing the 39 end of MALAT1 (Supplemental Fig. 5).
Secondary structure prediction of the minimal func-
tional MALAT1 39 end using Mfold indicated that the
A-rich tract should base-pair with U-rich motif 2 (Fig.
3A). As these potential base pairs are perfectly conserved
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through evolution (Fig. 1B,C), we generated cGFP-
MALAT1_39 expression plasmids in which specific base
pairs were disrupted (Fig. 3B; Supplemental Fig. 6). As
shown in Figure 3, C and D, the cGFP-MALAT1_39 RNA
failed to accumulatewhen twomismatcheswere introduced
in either U-rich motif 2 or the A-rich tract. When base-
pairing was re-established by introduction of mutations
in both motifs, a significant rescue in the level of cGFP-
MALAT1_39 RNA was detected (Fig. 3C,D). This in-
dicates that base-pairing between U-rich motif 2 and
Figure 2. The U-rich motifs inhibit uridylation and degradation of the 39 end of MALAT1. (A) Schematics of cGFP expression plasmids
used in this study. (Middle) To generate a cGFP transcript ending in a canonical poly(A) tail, the mMALAT1_39 region was replaced with
either the bovine growth hormone (bGH) or the SV40 polyadenylation signal. (Bottom) To generate a nuclear-retained cGFP transcript,
nucleotides 1676–3598 of mMALAT1 was placed upstream of cGFP. (B) Transfected HeLa cells were fractionated to isolate nuclear and
cytoplasmic total RNA, which was then subjected to Northern blot analysis with a probe to the cGFP ORF. A probe to endogenous
MALAT1 was used as a control for fractionation efficiency. (C) The SpeckleF2-MALAT1_39 transcript was efficiently retained in the
nucleus. (D) Mutations or deletions (denoted in red) were introduced into the mMALAT1_39 region of the CMV-cGFP-mMALAT1_39
expression plasmid. (E) The wild-type (WT) or mutant plasmids were transfected into HeLa cells, and Northern blots were performed.
RNase H treatment was performed prior to the Northern blot that detected cGFP-MALAT1_39 RNA. (F) A ligation-mediated 39 RACE
approach was used to examine the 39 ends of cGFP-MALAT1_39 transcripts undergoing degradation. Nucleotides added post-
transcriptionally are in red. (G) RNase H treatment followed by Northern blotting was used to show that the cGFP-MALAT1_39
Comp.14 transcript is stable. As 51 nt were deleted to generate the Comp.14 transcript, a band of only 139 nt is expected.
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the A-rich tract is critical for stabilizing the 39 end of
MALAT1. Interestingly, cGFP-MALAT1_39 ending in a
short homopolymeric poly(A) tail due to the GC in the
A-rich tract being mutated to AA was also degraded in
vivo (data not shown), indicating that a short poly(A) tail
cannot functionally replace base-pairing at the 39 end of
MALAT1. As expected, when 6 base pairs (bp) were dis-
rupted, the mutated cGFP-MALAT1_39 transcript failed
to accumulate in vivo (Fig. 3E). Unexpectedly, however,
introduction of compensatorymutations that re-establish
these 6 bp failed to rescue cGFP-MALAT1_39 transcript
levels (Fig. 3E), indicating that base-pairing between
U-rich motif 2 and the A-rich tract is necessary but not
sufficient for MALAT1 stability.
As U-rich motif 1 is also required for MALAT1 39 end
stability (Fig. 2E), is highly conserved (Fig. 1B,C), and is
predicted to be in close proximity to U-rich motif 2 and
the A-rich tract (Fig. 3A), we suspected that U-rich motif
1 may also interact with the duplex in, for example,
a triple helix (Fig. 4A). Pioneering work by Felsenfeld,
Davies, and Rich in 1957 (Felsenfeld et al. 1957) first
described U-A•U triple helix structures where a poly(U)
third strand forms Hoogsteen hydrogen bonds to the
major groove of a Watson-Crick base-paired helix of
poly(A)/poly(U) (Fig. 4B). Naturally occurring U-A•U
RNA triple helix structures have recently been identified
in telomerase RNA (Qiao and Cech 2008) and at the 39
end of a noncoding RNA produced by Kaposi’s sarcoma-
associated herpesvirus and related g-herpesviruses (Mitton-
Fry et al. 2010; Tycowski et al. 2012). In the latter case, this
structure was essential for stabilization of the RNA. C-G•C
triple helices are structurally similar to U-A•U, although
protonation of the cytosine in the third strand is required
to fully stabilize the structure, making C-G•C triplexes
favorable under acidic conditions (Fig. 4B). Importantly, at
the 39 ends of MALAT1 and MEN b, the U- and A-rich
Figure 3. Base-pairing between U-rich motif 2 and the A-rich tract is necessary but not sufficient for MALAT1 stability. (A) Predicted
secondary structure of the 39 end of the mature Comp.14 transcript. Denoted in purple are base pairs between U-rich motif 2 and the
A-rich tract that were mutated in C–E. (B) Mutations (denoted in red) were introduced into the CMV-cGFP-mMALAT1_39 expression
plasmid. The full 174-nt mMALAT1_39 region was present in these plasmids, although only the region between U-rich motif 2 and the
A-rich tract is shown. (C–E) The wild-type (WT) or mutant plasmids were transfected into HeLa cells, and Northern blots were
performed. RNase H treatment was performed prior to the Northern blots detecting cGFP-MALAT1_39 RNA.
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Figure 4. A triple helix forms at the 39 end of MALAT1. (A) Base triples (denoted by dashed lines) form at the 39 end of the mature Comp.14
transcript. This structure is similar to that shown in Figure 3A except that the orientation of the conserved stem–loop has been rotated by 90°.
The U-A•U base triples that were mutated in E are denoted in purple. (B) U-A•U and C-G•C base triples form via Hoogsteen hydrogen bonds to
the major grove of a Watson-Crick base-paired helix. (C) Rosetta model of the MALAT1 Comp.14 39 end in cartoon representation. Bases 1–5
are not included to achieve modeling convergence. As in A, U-rich motif 1 is in green, U-rich motif 2 is in red, and the A-rich tract is in blue.
Remaining bases are in gray. (D) Close-up view of the triple helix surrounding the nonbonded base C-11 (numbering as in A). Bases are shown
in stick representation with Watson-Crick hydrogen bonds in black and Hoogsteen hydrogen bonds in red. (E) Four of the U-A•U base triples
were progressively converted to C-G•C base triples in the CMV-cGFP-mMALAT1_39 expression plasmid. In the name of each construct, the
asterisk represents the Hoogsteen hydrogen bonds. The wild-type (WT) or mutant plasmids were then transfected into HeLa cells, andWestern
blots were performed to detect cGFP protein expression. Vinculin was used as a loading control. (F) Mutations (denoted in red) were introduced
into the CMV-cGFP-mMALAT1_39 expression plasmid. The full 174-nt mMALAT1_39 region was present in these plasmids, although only
the region around U-rich motif 1 is shown. Note that the 59 end of each transcript is on the right side to allow a direct comparison with the
structure in A. The wild-type (WT) or mutant plasmids were then transfected into HeLa cells, and Northern blots were performed.
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motifs are properly oriented to allow an intramolecular
triple-helical structure to form by Hoogsteen hydrogen-
bonding ofU-richmotif 1 to themajor groove of theWatson-
Crick base-paired helix that is formed by U-rich motif 2 and
the A-rich tract (Fig. 4A).
To assess the ability of the 39 end of MALAT1 to form
a triple helix, we used fragment assembly of RNA with
full atom refinement, known as FARFAR (Das et al. 2010).
This Rosetta-based algorithm predicts low-energy ter-
tiary RNA structures de novo to near-atomic resolution
(Das and Baker 2007). As shown in Figure 4C, the 59-nt
Comp.14 mMALAT1_39 region is predicted to be able to
fold into a barbell-like structure with loops at each end
of a continuous Watson-Crick base-paired helix, part of
which further forms a triple-helical structure with U-rich
motif 1 binding in the major groove. Nine U-A•U base
triples are able to form by base-pairing between the
Hoogsteen face of the A nucleotides in the A-rich tract
and the Watson-Crick face of the U nucleotides of U-rich
motif 1 (Fig. 4C,D; Supplemental Fig. 7). We note that our
modeling does not support the formation of a C-G•C
triple. Although FARFAR does not allow modeling of
a protonated cytidine residue at the Hoogsteen base (Fig.
4D), other steric constraints may preclude formation of
this C-G•C triple. The predicted structure lacks chain
breaks and has reasonable stereochemistry, indicating
that there are no structural constraints blocking the
formation of the triple helix. Nicely, nucleotides that
are not critical for MALAT1 39 end stability and thus are
deleted from the Comp.14 transcript (Fig. 2D) are all
predicted to be in loop regions at the ends of the barbell-
like structure, physically separated from the core triple
helix (Fig. 4A,C). Furthermore, the structural model
indicates that the 39-terminal nucleotide of MALAT1 is
part of the core triple helix and thus is well protected
from addition of either nontemplated nucleotides or
exonucleases. It is likely that significant free energy
would be necessary to unwind this triple helix. Consis-
tent with this model, 39 RACE revealed that 39–59 exo-
nucleases often pause within this structure (Fig. 2F).
Although the structural model predicts that the triple
helix structure can form, it does not prove that the triple
helix does form in vivo. Nevertheless, we have several
independent lines of evidence that support the existence
and functional significance of the triple helix in vivo.
First, all of the base triples are nearly perfectly conserved
through evolution at the 39 ends of both MALAT1 (Fig.
1B) and MEN b (Fig. 1C). Second, the mutational analysis
in Figure 3 revealed that base-pairing between U-rich
motif 2 and the A-rich tract is necessary but not suffi-
cient for stabilizing the 39 end of MALAT1. Of particular
interest is the Mut U2/A-CGAAAA transcript (Fig. 3B,E),
in which nucleotides that form six of the base pairs be-
tween U-rich motif 2 and the A-rich tract were swapped
across the helix. These nucleotide swaps should not alter
the structural integrity of the double helix but should
eliminate the potential to form base triples, providing
indirect support for this structure in the stabilization of
MALAT1. Third, to directly test for the presence of the
triple helix in vivo, we investigated the effect of convert-
ing four of the U-A•U base triples at the 39 end of
MALAT1 (denoted in purple in Fig. 4A) to C-G•C base
triples (Fig. 4E). Mutating the four consecutive A nucle-
otides to G (Fig. 4E, lane 4) caused the cGFP-MALAT1_39
transcript to be unstable and not translated in vivo (see
below for further information about translation). Com-
pared with a transcript only able to form a double helix
with C-G base pairs (Fig. 4E, lane 5), significantly greater
protein expression was observed when C-G•C base triples
were able to form (Fig. 4E, lane 6). This is strong evidence
that a functional triple helix forms in vivo.
To then investigate whether the entire triple helix
structure is necessary for stabilizing the 39 end of
MALAT1 in vivo, we generated cGFP-MALAT1_39 ex-
pression plasmids in which select base triples were
disrupted by mutating U-rich motif 1 (Fig. 4F). Interest-
ingly, we found that mutations in the middle of U-rich
motif 1 (Mut U1.1 and Mut U1.2) had no effect on cGFP-
MALAT1_39 transcript levels (Fig. 4F). This result is
consistent with data from Figure 3, C and D, where
base-pairing between U-rich motif 2 and the A-rich tract
in this middle region was necessary for RNA stability, but
the identities of the nucleotides on either side of the
double helix (and thus the ability to form a base triple or
not) were not critical. In contrast, base triples at both ends
of the triple helix are critical for cGFP-MALAT1_39 to be
stable (Mut U1.3 to Mut U1.5) (Fig. 4F). These results
support a model in which U-A•U base triples at each end
of theMALAT1 triple helix ensure the structural stability
of the overall structure and prevent transcript degrada-
tion by 39–59 exonucleases.
The triple helix structure also functions
as a translational enhancer element
As the cGFP-MALAT1_39 reporter mRNA is stable and
efficiently exported to the cytoplasm (Fig. 2B), we in-
vestigated whether the cGFP ORF is translated. Surpris-
ingly, similar levels of protein expression were observed
from the cGFP transcripts ending in the mMALAT1_39
region as compared with those ending in a poly(A) tail
(Fig. 5A). This suggests that the 39 end of MALAT1 may
also function to promote translation. The 39 end ofMEN b
similarly supported significant cGFP protein expression
(Supplemental Fig. 3C). These results are particularly
surprising considering that endogenous MALAT1 and
MEN b are nuclear-retained transcripts and thus are not
thought to interact with the translation machinery.
To better quantitate the translational output obtained
from a transcript ending in the MALAT1 39 end versus
that obtained from a transcript ending in a poly(A) tail, we
took advantage of a two-color fluorescent reporter system
recently developed by our laboratory that allows mea-
surements of gene expression in single mammalian cells
(Mukherji et al. 2011). This construct consists of a bi-
directional Tet-inducible promoter that drives expression
of the fluorescent proteins mCherry and enhanced yellow
fluorescent protein (eYFP) tagged with nuclear localiza-
tion sequences (Fig. 5B). In the 39 UTR of mCherry, we
inserted either the SV40 polyadenylation signal or the
A triple helix stabilizes long noncoding RNA 39 ends
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mMALAT1_39 region. In contrast, the 39 UTR of eYFP
always ended with the SV40 polyadenylation signal, allow-
ing eYFP expression to serve as an internal normalization
control, as it is a sensitive reporter of transcriptional and
translational activity from the bidirectional promoter.
Using flow cytometry to monitor protein expression in
Figure 5. The MALAT1 triple helix functions as a translational enhancer element. (A) Plasmids expressing cGFP transcripts ending in
the designated 39 end sequences were transfected into HeLa cells. The mMALAT1_39 region and the polyadenylation signals were
inserted in either the sense or antisense direction as denoted. Western blots were performed to detect cGFP protein expression.
Vinculin was used as a loading control. (B) Schematic of the two-color fluorescent reporter expression system. (C) The two-color
expression plasmids were transiently transfected into HeLa cells, and flow cytometry was used to measure mCherry and eYFP protein
expression in single cells. Shown are box plots of the ratios of mCherry to eYFP protein expression measured in individual transfected
cells ([horizontal line] median; [box] 25th–75th percentile; [error bars] 1.53 interquartile range) from a representative experiment (n = 3).
(D) qPCR was used to measure the ratio of mCherry mRNA to eYFP mRNA in populations of cells transfected with the two-color
expression plasmids. The data were normalized to the polyadenylated construct and are shown as mean and standard deviation values
of three independent experiments. (E) Mutations or deletions (denoted in red) were introduced into the mMALAT1_39 region of the
CMV-cGFP-mMALAT1_39 expression plasmid. (F) The wild-type (WT) or mutant plasmids were then transfected into HeLa cells, and
Northern blots were performed. RNase H treatment was performed prior to the Northern blot that detects cGFP-MALAT1_39 RNA. (G)
Western blotting was used to detect cGFP expression in the transfected HeLa cells. (H) Transfected HeLa cells were fractionated to
isolate nuclear and cytoplasmic total RNA, which was then subjected to Northern blot analysis. (I) Nucleotides that function in
promoting translation (denoted in purple) flank the triple-helical region at the 39 end of MALAT1.
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single cells, we first compared the levels of mCherry and
eYFP protein obtained when both transcripts terminated
in a canonical poly(A) tail. By calculating the ratio of
mCherry to eYFP protein detected in each analyzed cell,
we found that the expression of the fluorescent proteins
is, as expected, highly correlated (ratio of 0.916 0.05) (Fig.
5C; Supplemental Fig. 8A). This correlation was mirrored
on the transcript level when measured across the pop-
ulation of cells by quantitative PCR (qPCR) (Fig. 5D). We
then compared the levels of mCherry and eYFP proteins
and mRNAs obtained when the mMALAT1_39 region
was inserted downstream from mCherry. Consistent
with the results with the cGFP reporter in Figure 5A,
the mMALAT1_39 region supported strong translation
(mCherry/eYFP protein ratio of 1.00 6 0.05) (Fig. 5C,D;
Supplemental Fig. 8B). Northern blots confirmed that the
mCherry transcript ended in the mMALAT1_39 region as
generated by RNase P, thus eliminating the possibility
that a cryptic polyadenylation signal was responsible for
the efficient translation observed (Supplemental Fig. 8E).
To determine the sequence elements in themMALAT1_39
region required for efficient translation, we mutated the
cGFP-MALAT1_39 Comp.14 transcript (Fig. 2D), which
contains the minimal elements required for RNA stabil-
ity (Figs. 2G, 5F) and efficient translation (Fig. 5G), to test
whether a transcript that is stable but poorly translated
could be identified. By mutating every nucleotide at the
39 end of MALAT1 not present in the core triple-helical
region (while maintaining base-pairing in the conserved
stem–loop) (Comp.15) (Fig. 5E), a cGFP transcript that is
stable (Fig. 5F) but poorly translated (Fig. 5G) was identi-
fied. The Comp.15 transcript was exported to the cyto-
plasm as efficiently as Comp.14, indicating that this
decrease in translational efficiency is not due to increased
nuclear retention of the transcript (Fig. 5H). Confirming
these results, when the mMALAT1_39 Comp.15 region
was placed downstream from mCherry in the two-color
fluorescent reporter system (Fig. 5B), an approximately
fivefold decrease in translational efficiency was observed
when compared with the wild-typemMALAT1_39 region,
while the level of mRNA decreased only approximately
twofold (Fig. 5C,D; Supplemental Fig. 8C,D).
Additional mutagenesis was then performed to deter-
mine which of the 27 mutations present in the Comp.15
region were required for this decrease in translational
efficiency (Fig. 5E). Interestingly, this analysis revealed
that certain subsets of the 27 mutations (Comp.27) (Fig.
5E) caused the transcript to no longer be stable (Fig. 5F).
Nevertheless, we were able to identify other subsets of
mutations (Comp.25 and Comp.26) (Fig. 5E) that gener-
ated a stable cGFP transcript (Fig. 5F) that was poorly
translated (Fig. 5G). This indicates that the nucleotides
immediately flanking each side of the core triple-helical
region have critical roles in promoting translation (Fig. 5I).
As these results indicate that a strong translational
enhancer element is present at the 39 end ofMALAT1 and
MEN b, we investigated whether there was any evidence
of translation of these endogenous noncoding RNAs. Al-
though the MEN b transcript is lowly expressed in mouse
embryonic stem (ES) cells (data not shown), MALAT1 is
highly expressed, and ribosome profiling (Ingolia et al.
2011) suggests that reproducible and nonrandom regions
near the 59 end of MALAT1 are protected by ribosomes
(Fig. 6). We were unable to identify obvious well-conserved
ORFs in these regions, although it may be that species-
specific short peptides are produced from the 59 end of
MALAT1, as there are potential start codons in mice near
several of the regions where ribosomes are concentrated.
A transcript ending in the MALAT1 triple helix
is efficiently repressed by microRNAs
As most long transcripts lacking a poly(A) tail are rapidly
degraded in cells, it has generally been difficult to define
regulatory roles for the poly(A) tail or poly(A)-binding
protein (PABP) in vivo. Now, the expression system built
around the 39 end of MALAT1 represents a unique and
valuable tool to address these issues, as it generates in
vivo stable transcripts that lack a poly(A) tail. It is
unlikely that transcripts with mMALAT1_39 sequences
at their 39 ends interact with PABP, since this protein
requires at least 12 consecutive A residues for binding
(Sachs et al. 1987). To demonstrate the utility of our sys-
tem for investigating how nonpolyadenylated transcripts
are regulated in vivo, we asked whether microRNAs
repress a transcript ending in the MALAT1 triple helix
as efficiently as they do a polyadenylated transcript.
MicroRNAs function as part of RISC (RNA-induced silenc-
ing complex) and bind to partially complementary sites
in target mRNAs, causing translational repression and/or
transcript degradation (for review, see Bartel 2009). As the
core RISC protein componentGW182 can directly interact
with PABP as well as deadenylases (Braun et al. 2011), a
model has emerged in which an interaction between
RISC and PABP is required for maximum repression by
microRNAs (Fabian et al. 2009; Huntzinger et al. 2010;
Moretti et al. 2012). However, the functional importance
of these interactions has been debated (Fukaya and Tomari
2011; Mishima et al. 2012).
To investigate the role of the poly(A) tail in microRNA-
mediated repression in vivo, we took advantage of the
two-color fluorescent reporter system and inserted
microRNA-binding sites into the 39 UTR of mCherry
upstream of either the SV40 polyadenylation signal or the
mMALAT1_39 region (Fig. 7A). In particular, we inserted
either two bulged let-7-binding sites (denoted as let-7 bg)
or a sequence that is perfectly complementary to let-7
(denoted as let-7 pf), thus converting the interaction
between target and microRNA into a catalytic, RNAi-
type repression. Using HeLa cells that naturally express
let-7 microRNA, we found that when mCherry ended in
a canonical poly(A) tail, the addition of two bulged let-
7-binding sites caused 3.2 6 0.2-fold repression as mea-
sured by protein expression (Fig. 7B; Supplemental Fig. 9A).
Surprisingly, 2.96 0.4-fold repression was observed when
two bulged let-7 sites were added to mCherry ending in
the MALAT1 triple helix (Fig. 7B; Supplemental Fig. 9B),
a level of repression that is not statistically different from
that obtained when a poly(A) tail was present. Regardless
of whether mCherry ended in a poly(A) tail or in the
A triple helix stabilizes long noncoding RNA 39 ends
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MALAT1 triple helix, these effects were mirrored on the
transcript level (Fig. 7C), indicating that the effects on
protein production are likely at least partially due to
decreased RNA levels. Upon transfecting synthetic let-7
to increase the level of the microRNA in HeLa cells,
the levels of microRNA-mediated repression observed
increased consistently regardless of the 39-terminal se-
quence present (Fig. 7B,C). These results suggest that a
poly(A) tail is not necessary for maximum repression by
microRNAs in vivo and thus that microRNAs may also
efficiently target nonpolyadenylated transcripts in cells.
Although the mechanism by which nonpolyadenylated
transcripts are degraded in response to microRNAs is
unclear, these results suggest that deadenylation may
not always be required for efficient microRNA-mediated
silencing.
Discussion
Despite lacking a poly(A) tail, the long noncoding RNA
MALAT1 is a stable transcript that is expressed at a level
comparable with or higher than many protein-coding
genes in vivo (Wilusz et al. 2008; Zhang et al. 2012). In
the present study, we demonstrated that the 39 end of
MALAT1 is protected from degradation by an evolution-
arily conserved triple helix. We further identified a highly
similar triple-helical structure that stabilizes the 39 end
of the MEN b long noncoding RNA. Surprisingly, these
triple-helical regions also function as strong translational
enhancer elements, allowing a nonpolyadenylated mRNA
to be translated as efficiently as anmRNAwith a canonical
poly(A) tail. Transcripts ending in a triple helix are effi-
ciently repressed bymicroRNAs, arguing that a poly(A) tail
is not required for efficient microRNA-mediated silencing
in vivo. Our data provide new insights into howMALAT1,
MEN b, and likely other transcripts that lack poly(A) tails
are stabilized and regulated in vivo.
A triple helix can functionally replace a poly(A) tail
The poly(A) tail at the 39 ends of long RNA Pol II tran-
scripts functions to ensure that themature RNA is stable,
exported to the cytoplasm, and efficiently translated (for
review, see Zhao et al. 1999). It has long been known that
a stem–loop structure functionally replaces the poly(A)
tail at the 39 ends of replication-dependent histone mRNAs
(for review, see Marzluff et al. 2008). Our work has
demonstrated that the triple-helical structures at the 39
ends of the MALAT1 and MEN b long noncoding RNAs
can likewise functionally replace a poly(A) tail. In addi-
tion to supporting transcript stability, these triple helices
support efficient export (Fig. 2B) and translation (Fig. 5) of
a reporter transcript. The endogenous noncoding RNAs
are not exported, however, as nuclear retention signals
elsewhere in the transcripts (Fig. 2C) somehow override
any export signals present at the 39 ends. Interestingly,
Figure 6. Ribosome footprints are observed near the 59 end of MALAT1 in mouse ES cells. The RNA sequencing (RNA-seq) and
ribosome footprint profiles of MALAT1 in mouse embryoid bodies and mouse ES cells (grown in the presence or absence of leukemia
inhibitory factor [LIF]) as determined by Ingolia et al. 2011 are shown. The MALAT1 transcription start site is denoted by an arrow on
the right side of the figure.
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the various functions ascribed to the triple-helical region
can be separated from one another, as we were able to
identify mutations that generate a stable and exported
transcript that is not efficiently translated. Identifying
the mechanism by which the triple-helical region pro-
motes translation may reveal important new modes of
translational control.
PAN (polyadenylated nuclear) RNA, an abundant long
noncoding RNA generated by Kaposi’s sarcoma-associ-
ated herpesvirus, has previously been shown to also have
a triple helix at its 39 end (Mitton-Fry et al. 2010). Unlike
MALAT1 and MEN b, PAN RNA is subjected to canon-
ical cleavage/polyadenylation and binds PABP (Borah
et al. 2011). Nevertheless, five consecutive U-A•U base
triples form between part of the PAN RNA poly(A) tail
and a U-rich region ;120 nt upstream of the poly(A) tail
(Mitton-Fry et al. 2010). Formation of this triple helix
inhibits RNA decay and has been proposed to be required
for nuclear retention of PAN RNA. In contrast, we found
that the MALAT1/MEN b triple helices are not critical
for nuclear retention (Fig. 2B). Using the PAN RNA triple
helix structure as a guide, recent computational work
identified six additional transcripts that likely form triple
helices, although two of them were simply PAN RNA
homologs in related g-herpesviruses (Tycowski et al.
2012). The MALAT1 and MEN b triple helices were not
identified in this study, likely due to the subtle differ-
ences in these structures compared with the PAN RNA
triple helix. Considering that base triples can be formed
by nucleotides far away from one another in a transcript’s
primary sequence (or even be encoded on separate in-
dependent transcripts), additional functional RNA triple
helices likely form in vivo and await discovery.
In addition to the histone stem–loop structure and the
MALAT1/MEN b triple helices, other RNA structural
motifs may be able to functionally replace a poly(A) tail.
For example, it is known that tRNA-like structures
stabilize the 39 ends of several ssRNA viruses, such as
Figure 7. A transcript ending in the MALAT1
triple helix is efficiently repressed by microRNAs
in vivo. (A) Inserted into the 39 UTR of mCherry
was either a sequence perfectly complementary
to let-7 or two bulged let-7-binding sites. The
let-7 microRNA sequence is shown in blue.
(B) HeLa cells were transfected with two-color
fluorescent reporter plasmids ending in either the
SV40 polyadenylation signal or the mMALAT1_39
region with or without (denoted 0x) microRNA-
binding sites. In addition, 40 nM control siRNA
or exogenous let-7 microRNA was cotransfected
as indicated. Flow cytometry was then used to
measure mCherry and eYFP protein levels. Rela-
tive fold repression was calculated as the ratio of
the mean mCherry to the mean eYFP signal of
the targeted construct normalized to the equiv-
alent ratio for the nontargeted (0x) reporter. Data
are shown as mean and standard deviation values
of three independent experiments. (C) qPCR was
used to measure mCherry and eYFP transcript
levels across the population of cells, and the rel-
ative fold repression of mCherry RNA expression
was calculated analogously to above. Data are
shown as mean and standard deviation values
of three independent experiments.
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turnip yellow mosaic virus and bacteriophage Qb (for
review, see Fechter et al. 2001). To begin to screen for
other stabilizing RNA structures, we modified our CMV-
cGFP-mMALAT1_39 expression plasmid by replacing the
region of MALAT1 upstream of the RNase P cleavage site
with the sequences of various riboswitches, RNA ele-
ments that bind cellular metabolites and often fold into
elaborate structures (Supplemental Fig. 10; for review, see
Serganov and Patel 2012). As the mascRNA tRNA-like
structure is present immediately downstream from the
39 end of the riboswitch, RNase P cleavage generates a
mature cGFP transcript ending in the riboswitch se-
quence in vivo. Interestingly, the Thermoanaerobacter
tengcongensis glmS catalytic riboswitch, which senses
glucosamine-6 phosphate (Klein and Ferre-D’Amare 2006),
was able to stabilize the 39 end of the cGFP message and
support translation, although the effects were much
weaker than that obtained with the MALAT1 triple helix
(Supplemental Fig. 10). Nevertheless, these results suggest
that there are indeed likely additional RNA sequences
that are sufficient to stabilize the 39 ends of nonpolyade-
nylated transcripts. We believe that this expression
system provides an ideal method for in vivo screening
for these sequences, as our approach efficiently generates
transcripts that have a well-defined 39 end and lack
a poly(A) tail in vivo.
A growing role for uridylation in RNA degradation
Disrupting the integrity of the MALAT1 triple helix
causes the transcript to be efficiently degraded. We surpris-
ingly found numerous cGFP-MALAT1_39 transcripts end-
ing in post-transcriptionally added short U-rich tails when
the transcript was undergoing degradation (Fig. 2F; Sup-
plemental Fig. 4C), implicating uridylation in the decay
process. Oligouridylation has been linked to the degrada-
tion of numerous classes of small RNAs, including tRNAs
(Supplemental Fig. 1), microRNA precursors (Heo et al.
2009), mature microRNAs (Li et al. 2005), and transcrip-
tion start site-associated RNAs (Choi et al. 2012). Al-
though there is currently less evidence for U-tails on
long transcripts in vivo, uridylation can promote mRNA
decapping (Song and Kiledjian 2007; Rissland and Norbury
2009), and U-tails have been observed on the products of
microRNA-directed cleavage (Shen and Goodman 2004).
Interestingly, histone mRNAs are subjected to uridyla-
tion and degradation following the completion of DNA
synthesis (Mullen andMarzluff 2008). Analogous to what
we observed at the highly structured 39 end of MALAT1
(Fig. 2F; Supplemental Fig. 4C), Mullen and Marzluff
(2008) observed short U-tails on histone mRNAs that
appeared to have been shortened previously by 39–59
exonucleases. We further observed a similar phenomenon
at the 39 end of a mutantmascRNA transcript targeted for
degradation (Supplemental Fig. 1). These results suggest
that oligouridylation may play a much more significant
role in the degradation of regions of extensive RNA
secondary structure than we currently appreciate. In
particular, we suggest that when a 39–59 exonuclease stalls
at a region of extensive secondary structure, an oligo(U) tail
can be added to provide a single-stranded tail that is
subsequently recognized by decay factors and used to
restart the degradation process.
Implications of the triple helix for the functions
of MALAT1 and MEN b
Unlike many long noncoding RNAs that are rapidly
degraded and thus expressed at near undetectable levels
(Wyers et al. 2005; Preker et al. 2008), MALAT1 and
MEN b are stable transcripts with half-lives of >12 h
(Wilusz et al. 2008; Sunwoo et al. 2009). By preventing
degradation from the 39 ends of these noncoding RNAs,
the triple helices play a critical role in not only ensuring
RNA stability but also allowing these transcripts to per-
form important cellular functions. For example, the
MEN b noncoding RNA is an essential structural com-
ponent of paraspeckles in the nucleus (Sunwoo et al.
2009). When MEN b is depleted from cells, this sub-
nuclear domain is no longer observed, and paraspeckle-
associated proteins and RNAs instead are dispersed. The
exact cellular function of MALAT1 is currently a matter
of contention, as conflicting results have been published
(Tripathi et al. 2010; Yang et al. 2011b; Eissmann et al.
2012; Zhang et al. 2012). Nevertheless, MALAT1 is com-
monly overexpressed inmany cancers, suggesting a possible
role in a malignant phenotype.
Our finding that theMALAT1 andMEN b triple helices
function as strong translational enhancer elements adds
an additional unexpected twist to how these nuclear-
retained transcripts may function. Considering that the
Xist long noncoding RNA evolved from a protein-coding
gene (Duret et al. 2006), it may be that the same is true for
MALAT1 and MEN b, and thus their associated trans-
lation control elements are simply relics of their evolu-
tionary pasts. Alternatively, these noncoding RNAs may
interact with ribosomes, possibly producing short pep-
tides, as has been shown for other transcripts that were
once considered noncoding (Galindo et al. 2007; Ingolia
et al. 2011). Reproducible and nonrandom ribosome foot-
prints were found on MALAT1 in mouse ES cells (Fig. 6),
although no obvious well-conserved ORFs were identified.
It is also possible that MALAT1 and MEN b may simply
interact with components of the translation machinery,
thereby serving as a ‘‘sponge’’ that prevents the binding of
these factors to mRNAs.
Finally, the availability of expression vectors that pro-
duce stable cytoplasmic mRNAs without a poly(A) tail
will allow the in vivo testing of mechanisms for trans-
lational control involving this nontemplate-encoded
structure. For example, we found that microRNAs regu-
late the expression of target mRNAs with a poly(A) tail as
efficiently as mRNAs ending with the MALAT1 triple
helix.
In summary, we identified highly conserved triple-
helical structures at the 39 ends of the nonpolyadenyl-
ated MALAT1 and MEN b long noncoding RNAs, which
function to prevent RNA decay. When placed down-
stream from an ORF, the triple helices additionally
function to promote efficient translation. Our findings
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thus reveal novel paradigms for how transcripts that
lack a canonical poly(A) tail can be stabilized, regulated,
and translated. Considering the complexity of the hu-
man transcriptome and the presence of many other long
transcripts that may lack a poly(A) tail, it is likely that
triple helices and other RNA structural elements may
have additional unappreciated roles in ensuring tran-
script stability and regulating gene expression.
Materials and methods
Expression plasmid construction
To generate the CMV-cGFP-mMALAT1_39 expression constructs,
we modified a previously described plasmid (Gutschner et al.
2011) in which the CMV promoter and the cGFP ORF were
cloned into the multicloning site of the pCRII-TOPO vector
(Life Technologies). Downstream from cGFP, we inserted the
mMALAT1_39 region (nucleotides 6581–6754 of GenBank acces-
sion no. EF177380) into the NotI cloning site in the sense
direction (to generate CMV-cGFP-mMALAT1_39 sense) or in
the antisense direction (to generate CMV-cGFP-mMALAT1_39
antisense). The NotI cloning site was similarly used to generate
CMV-cGFP expression plasmids ending in the SV40 polyadenyla-
tion signal, the bGH polyadenylation signal, the mMEN b_39
region, and all of the mutant mMALAT1_39 regions. To generate
the CMV-SpeckleF2-mMALAT1_39 expression plasmid, nucleo-
tides 1676–3598 of mouse MALAT1 was inserted into the EcoRV
and BstEII cloning sites of the CMV-cGFP-mMALAT1_39 sense
plasmid. The sequences of the inserts for all plasmids are
provided in Supplemental Table 1.
Transfections and RNA analysis
HeLa cells were grown at 37°C with 5% CO2 in Dulbecco’s
modified Eagle’s medium (DMEM) containing high glucose (Life
Technologies), supplemented with penicillin–streptomycin and
10% fetal bovine serum. CMV-cGFP expression plasmids were
transfected using Lipofectamine 2000 (Life Technologies), and
total RNAwas isolated using Trizol (Life Technologies) as per the
manufacturer’s instructions. Northern blots were performed as
previously described (Wilusz et al. 2008). For RNase H treat-
ments, 9 mg of total RNA was first mixed with 20 pmol of
antisense oligo and heated for 10 min to 65°C. After the
antisense oligos were allowed to anneal by slow cooling, the
RNA was treated with RNase H (New England Biolabs) for
30 min at 37°C and then subjected to Northern blot analysis.
Nuclear and cytoplasmic fractionation was performed as de-
scribed previously (Wilusz et al. 2008). All oligonucleotide probe
sequences are provided in Supplemental Table 2. 39 RACE PCR
using microRNA Cloning Linker 3 (Integrated DNA Technolo-
gies) was performed as previously described (Wilusz et al. 2008).
Protein analysis
Western blots were performed using the Nu-PAGE Bis-Tris
electrophoresis system (Life Technologies) as per the manu-
facturer’s instructions. The cGFP antibody was obtained from
GenScript, and the Vinculin antibody was obtained from Sigma-
Aldrich.
Two-color fluorescent reporter system
The two-color fluorescent reporter vector was previously described
(Mukherji et al. 2011) and contains the SV40 polyadenylation
signal in the 39UTR of mCherry. To replace this polyadenylation
signal with the mMALAT1_39 region, the EcoRV and AatII
cloning sites that flank the SV40 polyadenylation signal were
used. Target sites for let-7 were inserted into the 39 UTR of
mCherry using HindIII and SalI cloning sites, and the sequences
are provided in Supplemental Table 1. HeLa cells were seeded
at 175,000 cells per well of a 12-well plate for 20 h prior to
transfection of equivalent amounts (250 ng) of the reporter
plasmid and rtTA using Lipofectamine 2000. At the time of
transfection, the medium was changed to complete DMEM
supplemented with 2 mg/mL doxycycline (Sigma). Where indi-
cated, control siRNA (siGENOME nontargeting siRNA #2,
Dharmacon) or an siRNA equivalent of murine let-7g (Dharmacon)
were cotransfected at final concentrations of 40 nM. Flow cytom-
etry or RNA isolation was performed 18–20 h post-transfection.
Flow cytometry, qPCR, and raw data processing were performed
as previously described (Mukherji et al. 2011) and are further
described in the Supplemental Material.
Structural model prediction
De novo RNA folding was carried out using Rosetta version 3.4
(http://www.rosettacommons.org) (Das and Baker 2007; Das
et al. 2010). For a converging model of the 39 end of the MALAT1
Comp.14 transcript, the first 5 nt (AAGGG) were removed.
Suspected helical interactions were defined (all nine U-A•U base
triples were defined), and 2000 models were calculated. The
model converged between 3 and 4 A˚ (see Supplemental Fig. 7C).
The full-length (59-nt) Comp.14 39 end was subjected to the same
procedure, although convergence could not be achieved due to
high flexibility of the 59 end.
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